Evidence map›Paper›PMID 40686516›Full record

ArticleUrology case reports2025

Non-muscle invasive bladder cancer in a pregnant patient.

Návan van Jaarsveld, Jeff John

Abstract readCase Reports
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Návan van JaarsveldDivision of Urology, Department of Surgery, Frere Hospital and Walter Sisulu University, East London, 5200, South Africa.
Jeff JohnDivision of Urology, Department of Surgery, Frere Hospital and Walter Sisulu University, East London, 5200, South Africa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant bladder tumors during pregnancy are exceedingly rare and account for less than 2.5 % of all malignancies. NMIBC presents unique diagnostic and management challenges, particularly in balancing maternal and fetal outcomes. We describe a 29-year-old woman diagnosed with NMIBC at 10 weeks' gestation, presenting with macroscopic hematuria. Ultrasonography and MRI confirmed the diagnosis, and TURBT revealed a high-grade T1 NMIBC. Post-operative surveillance and deferred intravesical therapy ensured maternal and fetal safety. The case underscores the challenges in balancing oncological and obstetric outcomes. While TURBT is safe during pregnancy, comprehensive follow-up and post-partum BCG are critical for long-term disease control.

Indexed as

HematuriaNon muscle invasive bladder cancer (NMIBC)PregnancyTransurethral resection of bladder tumor (TURBT)

Identifiers

PMID40686516
PMCPMC12275059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.